Brian B. Liau, Ph.D.
Affiliations: | 2013 | Chemistry and Chemical Biology | Harvard University, Cambridge, MA, United States |
Area:
Organic synthesisGoogle:
"Brian Liau"Mean distance: 7.73 | S | N | B | C | P |
Parents
Sign in to add mentor| Elias James Corey | research assistant | Harvard | ||
| Matthew D. Shair | grad student | 2013 | Harvard | |
| (Total syntheses of fastigiatine and the hibarimicin aglycons.) | ||||
| Bradley E. Bernstein | post-doc | Harvard Medical School (Cell Biology Tree) | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kato S, Weng QY, Insco ML, et al. (2020) Gain-of-function genetic alterations of G9a drive oncogenesis. Cancer Discovery |
| Vinyard ME, Su C, Siegenfeld AP, et al. (2019) CRISPR-suppressor scanning reveals a nonenzymatic role of LSD1 in AML. Nature Chemical Biology. 15: 529-539 |
| Park Y, Koga Y, Su C, et al. (2019) A Versatile Synthetic Route to Cycloheximide and Analogues that Potently Inhibit Translation Elongation. Angewandte Chemie (International Ed. in English) |
| Miller TE, Liau BB, Wallace LC, et al. (2017) Transcription elongation factors represent in vivo cancer dependencies in glioblastoma. Nature |
| Park Y, Liau BB. (2017) Uncovering the Cellular Target of Agelastatin A. Cell Chemical Biology. 24: 542-543 |
| Liau BB, Sievers C, Donohue LK, et al. (2016) Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance. Cell Stem Cell |
| Xie Q, Wu Q, Kim L, et al. (2016) RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation. The Journal of Clinical Investigation |
| Flavahan WA, Drier Y, Liau BB, et al. (2015) Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature |
| van Galen P, Viny AD, Ram O, et al. (2015) A Multiplexed System for Quantitative Comparisons of Chromatin Landscapes. Molecular Cell |
| Pelish HE, Liau BB, Nitulescu II, et al. (2015) Mediator kinase inhibition further activates super-enhancer-associated genes in AML. Nature. 526: 273-6 |